Effectiveness of Safinamide over Mood in Parkinson's Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR.
Carmen M LabandeiraMaria G Alonso LosadaRosa Yáñez BañaMaria I Cimas HernandoIria Cabo LópezJose M Paz GonzálezMaria J Gonzalez PalmásCristina Martínez MiróDiego Santos GarcíaPublished in: Advances in therapy (2021)
Safinamide improves mood in patients with PD at 6 months.
Keyphrases
- open label
- end stage renal disease
- bipolar disorder
- ejection fraction
- newly diagnosed
- randomized controlled trial
- chronic kidney disease
- clinical trial
- systematic review
- peritoneal dialysis
- sleep quality
- prognostic factors
- squamous cell carcinoma
- study protocol
- radiation therapy
- phase ii
- patient reported
- locally advanced